Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02074839
Recruitment Status : Recruiting
First Posted : February 28, 2014
Last Update Posted : August 18, 2021
Sponsor:
Information provided by (Responsible Party):
Servier ( Institut de Recherches Internationales Servier )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2025
Estimated Study Completion Date : August 2025
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):